- Home
- TEO vs XENE Comparison
TEO vs XENE Comparison
Compare TEO & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEO
- XENE
- Stock Information
- Founded
- TEO 1979
- XENE 1996
- Country
- TEO Argentina
- XENE Canada
- Employees
- TEO N/A
- XENE N/A
- Industry
- TEO Telecommunications Equipment
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- TEO Telecommunications
- XENE Health Care
- Exchange
- TEO Nasdaq
- XENE Nasdaq
- Market Cap
- TEO 2.7B
- XENE 3.3B
- IPO Year
- TEO N/A
- XENE 2014
- Fundamental
- Price
- TEO $14.17
- XENE $40.51
- Analyst Decision
- TEO Sell
- XENE Strong Buy
- Analyst Count
- TEO 1
- XENE 8
- Target Price
- TEO $6.10
- XENE $56.00
- AVG Volume (30 Days)
- TEO 282.3K
- XENE 406.9K
- Earning Date
- TEO 11-07-2024
- XENE 02-27-2025
- Dividend Yield
- TEO N/A
- XENE N/A
- EPS Growth
- TEO N/A
- XENE N/A
- EPS
- TEO 0.21
- XENE N/A
- Revenue
- TEO $1,780,106,477.00
- XENE N/A
- Revenue This Year
- TEO $91.50
- XENE N/A
- Revenue Next Year
- TEO $39.96
- XENE $1,599.99
- P/E Ratio
- TEO $15.94
- XENE N/A
- Revenue Growth
- TEO N/A
- XENE N/A
- 52 Week Low
- TEO $5.52
- XENE $35.53
- 52 Week High
- TEO $14.79
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- TEO 61.90
- XENE 51.30
- Support Level
- TEO $12.40
- XENE $38.03
- Resistance Level
- TEO $13.70
- XENE $42.23
- Average True Range (ATR)
- TEO 0.94
- XENE 1.49
- MACD
- TEO 0.03
- XENE 0.10
- Stochastic Oscillator
- TEO 83.54
- XENE 63.48
About TEO Telecom Argentina SA
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company provides services in Argentina (mobile, cable television, Internet and fixed and data services), Paraguay (mobile, Internet and satellite TV services), Uruguay (cable television services) and the United States (fixed wholesale services).
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.